Drug Profile
Levodopa/carbidopa bi-layer tablet - Amneal Pharmaceuticals
Alternative Names: IPX-054Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator IMPAX Laboratories
- Developer Impax Pharmaceuticals
- Class Antiasthmatics; Antiparkinsonians; Aromatic amino acids; Catecholamines; Hydrazines; Small molecules
- Mechanism of Action Decarboxylase inhibitors; Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Parkinson's disease